Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update

- Mehta, Meenu, Dhanjal, Dalijeet S., Paudel, Keshav R., Singh, Bhupender, Gupta, Gaurav, Rajeshkumar, S., Thangavelu, Lakshmi, Tambuwala, Murtaza M., Bakshi, Hamid A., Chellappan, Dinesh K., Pandey, Parijat, Dureja, Harish, Charbe, Nitin B., Singh, Sachin K., Shukla, Shakti D., Nammi, Srinivas, Aljabali, Alaa A., Wich, Peter R., Hansbro, Philip M., Satija, Saurabh, Dua, Kamal

Employment of microRNA profiles and RNA interference and antagomirs for the characterization and treatment of respiratory disease

- Yang, Ming, Mattes, Joerg, Hansbro, Philip M., Foster, Paul S.

Immunological axis of berberine in managing inflammation underlying chronic respiratory inflammatory diseases

- Tew, Xin Nee, Lau, Natalie Jia Xin, Chellappan, Dinesh Kumar, Madheswaran, Thiagarajan, Zeeshan, Farrukh, Tambuwala, Murtaza M., Aljabali, Alaa AA., Balusamy, Sri Renukadevi, Perumalsamy, Haribalan, Gupta, Gaurav, Oliver, Brian G., Hsu, Alan, Wark, Peter, Reddy, Karosham, Wadhwa, Ridhima, Hansbro, Philip Michael, Dua, Kamal

Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems

- Dua, Kamal, Malyla, Vamshikrishna, Mehta, Meenu, Gulati, Monica, Hansbro, Nicole, Collet, Trudi, Awasthi, Rajendra, Gupta, Gaurav, Hsu, Alan, Hansbro, Philip M., Singhvi, Gautam, Wadhwa, Ridhima, Krishna, Rapalli Vamshi, Shukla, Shakti Dhar, Shastri, Madhur D., Chellappan, Dinesh Kumar, Maurya, Pawan Kumar, Satija, Saurabh

Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases

- Mehta, Meenu, Deeksha, Sharma, Neha, Vyas, Manish, Khurana, Navneet, Maurya, Pawan Kumar, Singh, Harjeet, Andreoli de Jesus, Terezinha Pinto, Dureja, Harish, Chellappan, Dinesh Kumar, Gupta, Gaurav, Wadhwa, Ridhima, Collet, Trudi, Hansbro, Philip M., Dua, Kamal, Satija, Saurabh

MicroRNAs in lung diseases

- Hoefel, Gabriela, Tay, Hock, Foster, Paul

Oligonucleotide therapy: an emerging focus area for drug delivery in chronic inflammatory respiratory diseases

- Mehta, Meenu, Deeksha,, Hansbro, Philip M., Kumar, S. Rajesh, Thangavelu, Lakshmi, Negi, Poonam, Dua, Kamal, Satija, Saurabh, Tewari, Devesh, Gupta, Gaurav, Awasthi, Rajendra, Singh, Harjeet, Pandey, Parijat, Chellappan, Dinesh Kumar, Wadhwa, Ridhima, Collet, Trudi

Patented therapeutic drug delivery strategies for targeting pulmonary diseases

- Thakur, Ajay Kumar, Chellappan, Dinesh Kumar, Dua, Kamal, Mehta, Meenu, Satija, Saurabh, Singh, Inderbir

Rhinoscleroma in Zambia

- Bhagwandeen, S. B.

Targeting eosinophils in respiratory diseases: biological axis, emerging therapeutics and treatment modalities

- Lee, Li-Yen, Hew, Geena Suet Yin, Singh, Pankaj Kumar, Gulati, Monica, Prasher, Parteek, Aljabali, Alaa A. A., Tambuwala, Murtaza M., Thangavelu, Lakkshmi, Panneerselvam, Jithendra, Gupta, Gaurav, Zacconi, Flavia C., Shastri, Madhur, Mehta, Meenu, Jha, Niraj Kumar, Xenaki, D, MacLoughlin, R, Oliver, BG, Chellappan, DK, Dua, Kamal, Shukla, Shakti D., Satija, Saurabh, Khurana, Navneet, Anand, Krishnan, Dureja, Harish, Singh, Sachin Kumar, Mishra, Vijay

Targeting MicroRNA function in respiratory diseases: mini-review

- Maltby, Steven, Plank, Maximillian, Tay, Hock L., Collison, Adam, Foster, Paul S.

Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases

- Chellappan, Dinesh K., Yee, Lim W., Satija, Saurabh, Singh, Sachin K., Gulati, Monica, Dureja, Harish, Da Silva, Mateus Webba, Tambuwala, Murtaza M., Gupta, Gaurav, Paudel, Keshav R., Wadhwa, Ridhima, Hansbro, Philip M., Xuan, Kong Y., Dua, Kamal, Kunalan, Kishen, Rou, Lim C., Jean, Leong S., Ying, Lee Y., Wie, Lee X., Chellian, Jestin, Mehta, Meenu

The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Prũnte, Laura, Lebender, Leonard F., Patel, Brijeshkumar S., Gelissen, Ingrid, Hansbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

TLR2-mediated innate immune priming boosts lung anti-viral immunity

- Girkin, Jason, Loo, Su-Ling, Knight, Darryl, Jackson, David, Demaison, Christophe, Bartlett, Nathan W., Esneau, Camille, Maltby, Steven, Mercuri, Francesca, Chua, Brendon, Reid, Andrew T., Veerati, Punnam Chander, Grainge, Chris L., Wark, Peter A. B.

Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell

- Girkin, Jason L. N., Maltby, Steven, Bartlett, Nathan W.